In any event, allegations that Novapharm had made the representations in trade or commerce permeate the proposed amended statement of claim and lie at the heart of Mr Glueck's claims. 42 Mr Glueck would not, of course, be asking this Court to revoke the US Patents. Associate:Dated: 27 February 2008 The Applicant appeared in person. Again, misleading or deceptive conduct in trade or commerce in contravention of s 52 of the TP Act is pleaded (in paras 30 and 32). 10 The respondents' motion for summary dismissal relates to the existing application and statement of claim.